VivoSim Labs (VIVS) Non-Current Assets (2011 - 2026)
VivoSim Labs (VIVS) posted Non-Current Assets of $621000.0 for Q2 2026, down 18.18% on a QoQ basis from $759000.0 in Q1 2026, and down 72.74% year-over-year from $2.3 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Non-Current Assets (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Non-Current Assets for 16 years, with the latest figure at $621000.0 in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 72.74% year-over-year to $621000.0 in Q2 2026; TTM through Jun 2026 was $4.4 million, a 48.48% decrease from a year earlier, with the FY2026 full-year figure at $759000.0, down 69.87% from the prior year.
- Non-Current Assets was $621000.0 for Q2 2026 at VivoSim Labs, down from $759000.0 in the prior quarter.
- The five-year high for Non-Current Assets was $3.8 million in Q1 2022, with the low at $621000.0 in Q2 2026.
- Average Non-Current Assets over 5 years is $2.4 million, with a median of $2.5 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Non-Current Assets soared 147.73% in 2022, then sank 72.74% in 2026.
- Over 5 years, Non-Current Assets stood at $3.5 million in 2022, then fell by 23.81% to $2.6 million in 2023, then tumbled by 33.94% to $1.7 million in 2024, then sank by 47.31% to $919000.0 in 2025, then plunged by 32.43% to $621000.0 in 2026.
- The last three Non-Current Assets figures came in at $621000.0 (Q2 2026), $759000.0 (Q1 2026), and $919000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.87 Bn | 41.92 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 17.09 Bn | 16.59 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Charles River Laboratories International | 13.27 Bn | 13.12 Bn | 452.07 Mn | 6.00 Bn |
| 4 | Icon | 12.57 Bn | 11.64 Bn | 479.29 Mn | 12.65 Bn |
| 5 | Fortrea Holdings | 1.90 Bn | 1.73 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 568.89 Mn | 143.02 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 502.68 Mn | 418.15 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 73.77 Mn | 69.94 Mn | 7.70 Mn | 14.00 Mn |
| 9 | MindWalk Holdings | 63.53 Mn | 58.06 Mn | 1.61 Mn | 3.66 Mn |
| 10 | VivoSim Labs | 1.21 Mn | 1.21 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 621,000.00 |
| Mar 31, 2026 | 759,000.00 |
| Dec 31, 2025 | 919,000.00 |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 2.87 Mn |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 3.27 Mn |
| Dec 31, 2022 | 3.47 Mn |
| Sep 30, 2022 | 3.55 Mn |
| Jun 30, 2022 | 3.64 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 1.58 Mn |